Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2019; 09(02): 81-84
DOI: 10.1055/s-0039-1693844
Case Report

Recurrent Infections in a Patient with Multiple Myeloma

Sanjay Kini
1   Department of Community Medicine, KS Hegde Medical Academy, Deralakatte, Mangalore, India
,
Aravind Shanbhag
2   Department of Orthopaedics, KS Hegde Medical Academy, Deralakatte, Mangalore, India
,
Sachin Chandramohan
1   Department of Community Medicine, KS Hegde Medical Academy, Deralakatte, Mangalore, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

An 80-year-old woman with recurrent urinary tract infection presented to the orthopaedic OPD at KS Hegde Memorial Health Center, Bailur, with gradual onset of generalized weakness, fatigue, anorexia, musculoskeletal pain, and particularly severe backache. The patient was diagnosed to have anemia but renal function tests were normal. X-ray spine showed multiple compression fractures. Serum electrophoresis confirmed the diagnosis of multiple myeloma. In an elderly patient with myalgia, anemia, and recurrent infections, the differential diagnosis of multiple myeloma should be kept in mind as it is often missed by clinicians.

Keywords

multiple myeloma - anemia - β2-microglobulin


Publication History

Received: 05 November 2018

Accepted: 05 January 2019

Article published online:
10 February 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Videa-Irias EO, Caballero A, Erazo D, Medina S. Multiple myeloma, a patient with multiple infections: a case report. Arch Cancer Res 2016; 4-3
    Google Scholar
  • 2 Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011; 364 (11) 1046-1060
    CrossrefPubMedGoogle Scholar
  • 3 Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM. et al. Clinical course and prognosis of smoldering (asymptomatic) multiple mieloma. N Engl J Med 2007; 356: 2582-2590
    CrossrefPubMedGoogle Scholar
  • 4 Bladé J. Clinical practice. Monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 355 (26) 2765-2770
    CrossrefPubMedGoogle Scholar
  • 5 David GA. Guíasmexicanas de diagnóstico y recomendacio-nesterapéuticas para mielomamúltiple. ReviHematologia 2009; 11: 40-62
    Google Scholar
  • 6 Ames J, Al-Samaraee A, Takahashi T. Extraosseous multiple myeloma: case report of presentation in the lower extremity soft tissues with literature review. Case Rep Radiol 2017; 2017: 9159035
    PubMedGoogle Scholar
  • 7 Hanrahan CJ, Christensen CR, Crim JR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics 2010; 30 (01) 127-142
    CrossrefPubMedGoogle Scholar
  • 8 Ramón GS, María VM. Mielomamúltiple, Servicio de Hematología. Hospital Universitario de Salamanca. Centro de InvestigacióndelCáncer, Salamanca. España. Med Clin (Barc) 2007; 129: 104-115
    PubMedGoogle Scholar
  • 9 Serra-Valdés M, Alfaro-Amigó A, Viera-García M. Síndrome de hiperviscosidadcomopresentación del myeloma múltiple. Reporteun de caso. Revista Finlay 2013; 3: 4 (revista en Internet)
    Google Scholar
  • 10 Barlogie B, Mitchell A, van RheeF, Epstein J, Morgan GJ, Crowley J. Curing myeloma at last: defining criteria and providing the evidence. Blood 2014; 124 (20) 3043-3051
    PubMedGoogle Scholar
  • 11 Heinz L, Brian GM, Vanessa B, Ingemar T, Kyle RA, Blade J. et al. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10,549 patients from the International Myeloma Working-Group. Blood 2008; 111: 4039-4047
    CrossrefPubMedGoogle Scholar
  • 12 Moreau P, Attal M, Facon T. Frontline therapy of multiple myeloma. Blood 2015; 125 (20) 3076-3084
    CrossrefPubMedGoogle Scholar
  • 13 Bladé J, Rosiñol L, Fernández de Larrea C. How I treat relapsed myeloma. Blood 2015; 125 (10) 1532-1540
    CrossrefPubMedGoogle Scholar